Neil Zeng
曾颖哲
Neil Zeng is a partner at Linear Capital, an early-stage investment firm founded in 2014 that focuses on "frontier technology + industry" applications . He previously served as partner at Future Capital Discovery Fund and has over 15 years of experience across operations, finance, and investments, including stints at Goldman Sachs' London office, Bosch Group, and as Vice President of corporate M&A at ChinaCache (NASDAQ: CCIH) . He holds a BA from Shanghai University of International Business and Economics and a Master's from the University of Surrey, and is fluent in Chinese, English, and Japanese .
At Linear Capital, Zeng has led or represented the firm in deals spanning digital therapeutics (Juehua Medical), synthetic biology (SynBioRay), green hydrogen (Kework Technology), and bio-materials modification (Yinghua Chenrui) . He was also a 2018 Young Global Leader of the World Economic Forum .
AI-generated — may contain errors, please verify.
Coverage
AI4S Doesn't Lack Stories; It Lacks Real Commercial Value | Linear Voice
"Discovery" is often not the hardest part.
线性资本·After the Start of Summer, Growing Without Reserve | Linear Quarterly
Abundant sunshine, lush growth.
线性资本·"Deep Principle" Closes Series A2 Round, Joins OpenAI and Others in *Science* to Discuss AI4S Exploration | Linear Portfolio
AI4S shouldn't stop at the "selling shovels" stage.
线性资本·Linear Capital's New Year Reading List Is Now Open Source — Trading Cognitive Upgrades with You | Linear Recommend
Capturing new signals at the cross-entropy of technology and the humanities.
线性资本·Where Are the Opportunities for China's AI4S Industry in Trump's "Genesis Project"? | Linear Voice
Standing at the historical inflection point of a new Age of Scientific Discovery.
线性资本·Linear Capital's 2025 Investor Conference Successfully Held in Beijing | Linear News
To be or not to be, in the AI-dominated future.
线性资本·Linear Capital's Yingzhe Zeng: Early-Stage Investing Isn't a Great Business Model — So Why Do We Keep at It? | Linear View
Knowing full well the path ahead was strewn with thorns, they still ran barefoot alongside the founders.
线性资本·Synthetic biology company "NewPro" has raised several million dollars in a seed round, with Linear Capital as the sole investor.
Accelerating the Commercialization of Fermentation-Derived Lactoferrin
线性资本·Linear Capital｜Linear Path, Nonlinear Growth
We strive to be the best Data Intelligence Technology Fund in China.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier tech and innovation fund.
线性资本·Green Carbon Synthesis, a company developing proprietary next-generation sustainable aviation fuel technology, has raised tens of millions of RMB in an angel round led by Linear Capital.
Green Carbon Synthesis has optimized the catalyst and process pathway based on conventional Fischer-Tropsch technology, independently developing a third-generation Fischer-Tropsch synthesis process for producing SAF.
线性资本·Event Recap | July 11: Linear Capital Welcomes Yingda Venture Capital Club Delegation
Linear Capital x Penn Venture Club
线性资本·Transforming the Industrial Landscape of Chemical Materials with AI | Linear Capital Portfolio Interview Series: "Deep Principle Technology"
Today, Deep Principle, a company focused on AI-driven scientific research in chemistry, announced the completion of a nearly $10 million seed funding round. Linear Capital led the round, with Zhenzhi Ventures and Taihill Venture participating as co-investors. XtalPi and DP Technology also joined as strategic industry investors. Founded in 2024, Deep Principle's founding members are all graduates of MIT. The company's vision is to integrate artificial intelligence, quantum...
线性资本·Using AI to Accelerate Discovery of Efficient Catalytic Materials, "Deep Principle Technology" Raises Nearly $10 Million in Seed Funding Led by Linear Capital
By Chen Sida | Edited by Deng Yongyi Source: Intelligent Emergence From household daily chemical products to high-efficiency catalysis for energy use, nearly every aspect of life and production depends on emerging materials. The old "needle in a haystack" trial-and-error approach can no longer meet today's materials R&D demands. But the AI boom sparked by the large model wave is bringing "AI alchemy" closer to reality.
线性资本·"贻如生物" Su Rui: How the World's First Continuously Produced 100% Bio-based Leather Was Achieved | Linear Capital Portfolio Interview Series
Today, SynMetabio, a Linear Capital seed-round lead portfolio company, announced it has raised tens of millions of RMB in a Pre-A round. One year after announcing its seed round from Linear Capital in April 2023, SynMetabio has made significant progress, **including optimizing its entire production process, substantially reducing manufacturing costs, and achieving cost advantages for bio-based materials in most application scenarios.** Next, SynMetabio will build a factory in Changzhou to scale up mass production of its synthetic leather.
线性资本·"Yinghua Chenrui" Zhou Zhen: Solving Biomaterial Industry Bottlenecks with Unique Modification Technology and Processing Techniques | Linear Capital Portfolio Interview Series
In late December 2023, bio-based materials high-performance modification and application innovation company **Yinghua Chenrui** announced the completion of a tens of millions of RMB angel funding round.
线性资本·Linear Capital｜Linear Path, Nonlinear Growth
We strive to be the best Data Intelligence Technology Fund in China.
线性资本·Linear Capital | Linear Path, Nonlinear Growth
Striving to become China's best frontier technology and innovation fund.
线性资本·Bio-materials high-performance modification and application innovation company "Yinghua Chenrui" raises tens of millions of RMB in angel funding, led by Linear Capital
Output high-performance bio-based material modification capabilities.
线性资本·Alkaline hydrogen production composite diaphragm manufacturer Kework Technology has raised tens of millions of yuan in a Pre-A funding round, led by Linear Capital.
Focused on alkaline hydrogen production composite separator membrane technology.
线性资本·Synthetic biology startup **SynBioRay** (贻如生物) has raised tens of millions of RMB in funding, with **Linear Capital** leading the angel round.
Using synthetic biotechnology to cultivate 100% bio-based leather.
线性资本·Brain science-based vision health startup Juehua Medical raises tens of millions of RMB in angel round, with Linear Capital as sole investor
36Kr has learned that neurotechnology medical company Juehua has completed an angel round of financing worth tens of millions of RMB, with Linear Capital as the investor and Qidian Capital serving as the financial advisor for this round. The funding will be used for product iteration, clinical data accumulation, and team building.
线性资本·Conversations with 29 Tech Investors: There Are Treasures, But No Treasure Map
Investing in tech is definitely the right call, but consensus remains scarce.
暗涌Waves·
